Drawing for ONCO/REVEAL

USPTO serial 87982295

ONCO/REVEAL

Reviewed by CopyMark Law Group

Reg. 6114090Status 700Renewal
Filing date
Status date
Registration date
Jul 28, 2020
Examiner
ALLEN, BIANCA LEIGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONCO/REVEAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marcus Assefa

Marcus Assefa PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics researchACTIVEMay 20, 2019
005Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancerACTIVEAug 26, 2019
009Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processingACTIVEAug 26, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 26, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 25, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 2020ALIEASSIGNED TO LIE—
May 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 13, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 13, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 13, 2019EX3GSOU EXTENSION 3 GRANTED—
Nov 11, 2019IUAFUSE AMENDMENT FILED—
Nov 11, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Nov 11, 2019EXT3SOU EXTENSION 3 FILED—
Nov 11, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 11, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 30, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 30, 2019NOACCORRECTED NOA E-MAILED—
May 29, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
May 29, 2019EX2GSOU EXTENSION 2 GRANTED—
May 29, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 10, 2019DRRRDIVISIONAL REQUEST RECEIVED—
May 10, 2019EXT2SOU EXTENSION 2 FILED—
May 10, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 10, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 15, 2018EXT1SOU EXTENSION 1 FILED—
Nov 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 8, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2017DOCKASSIGNED TO EXAMINER—
Sep 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance